Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose L Lopez-Ribot

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Journal of Clinical Microbiology|October 2, 2009
Characteristics of Candida albicans biofilms grown in a synthetic urine mediumPriya Uppuluri, Hemamalini Dinakaran, Derek P Thomas, et al.
BMC Research Notes|November 29, 2019
Protocol optimization for a fast, simple and economical chemical reduction synthesis of antimicrobial silver nanoparticles in non-specialized facilitiesRoberto Vazquez-Muñoz, M Josefina Arellano-Jimenez, Fernando D Lopez, et al.
Journal of Materials Science. Materials in Medicine|July 22, 2015
Effect of silver nanoparticle geometry on methicillin susceptible and resistant Staphylococcus aureus, and osteoblast viabilityLisa Actis, Anand Srinivasan, Jose L Lopez-Ribot, et al.
Current Opinion in Microbiology|May 16, 2019
Candida albicans biofilm growth and dispersal: contributions to pathogenesisGina Wall, Daniel Montelongo-Jauregui, Bruna Vidal Bonifacio, et al.
Msphere|July 7, 2017
<i>nBio</i>Chip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream ApplicationsAnand Srinivasan, Nelson S Torres, Kai P Leung, et al.
Infection and Immunity|October 31, 2007
Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient miceStephen P Saville, Anna L Lazzell, Ashok K Chaturvedi, et al.
General Dentistry|February 9, 2012
Sodium hypochlorite, chlorhexidine gluconate, and commercial denture cleansers as disinfecting agents against Candida albicans: An in vitro comparison studyAfaf A Dahlan, Carl W Haveman, Gordon Ramage, et al.
Clinical and Vaccine Immunology : CVI|January 16, 2009
Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasisStephen P Saville, Anna L Lazzell, Ashok K Chaturvedi, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 6, 2023
A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput ScreeningOlabayo H Ajetunmobi, Gina Wall, Bruna V Bonifacio, et al.
Journal of Fungi (Basel, Switzerland)|December 24, 2025
Drug Discovery and Repurposing for <i>Coccidioides</i>: A Systematic ReviewSarah Saeger, Sofia Lozano, Nathan Wiederhold, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of Clinical Microbiology|October 2, 2009
Characteristics of Candida albicans biofilms grown in a synthetic urine mediumPriya Uppuluri, Hemamalini Dinakaran, Derek P Thomas, et al.
BMC Research Notes|November 29, 2019
Protocol optimization for a fast, simple and economical chemical reduction synthesis of antimicrobial silver nanoparticles in non-specialized facilitiesRoberto Vazquez-Muñoz, M Josefina Arellano-Jimenez, Fernando D Lopez, et al.
Journal of Materials Science. Materials in Medicine|July 22, 2015
Effect of silver nanoparticle geometry on methicillin susceptible and resistant Staphylococcus aureus, and osteoblast viabilityLisa Actis, Anand Srinivasan, Jose L Lopez-Ribot, et al.
Current Opinion in Microbiology|May 16, 2019
Candida albicans biofilm growth and dispersal: contributions to pathogenesisGina Wall, Daniel Montelongo-Jauregui, Bruna Vidal Bonifacio, et al.
Msphere|July 7, 2017
<i>nBio</i>Chip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream ApplicationsAnand Srinivasan, Nelson S Torres, Kai P Leung, et al.
Infection and Immunity|October 31, 2007
Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient miceStephen P Saville, Anna L Lazzell, Ashok K Chaturvedi, et al.
General Dentistry|February 9, 2012
Sodium hypochlorite, chlorhexidine gluconate, and commercial denture cleansers as disinfecting agents against Candida albicans: An in vitro comparison studyAfaf A Dahlan, Carl W Haveman, Gordon Ramage, et al.
Clinical and Vaccine Immunology : CVI|January 16, 2009
Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasisStephen P Saville, Anna L Lazzell, Ashok K Chaturvedi, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 6, 2023
A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput ScreeningOlabayo H Ajetunmobi, Gina Wall, Bruna V Bonifacio, et al.
Journal of Fungi (Basel, Switzerland)|December 24, 2025
Drug Discovery and Repurposing for <i>Coccidioides</i>: A Systematic ReviewSarah Saeger, Sofia Lozano, Nathan Wiederhold, et al.
Pageof 9